University Of Hong Kong English news | University Of Hong Kong, Latest News & Live Updates in English | English News (Latest English News) at Lokmattimes.com

Hong Kong, July 28 A team of researchers has developed an inhalable dry powder formulation of tamibarotene a repurposed drug which has showed broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV and influenza A H1N1 virus following pulmonary delivery in animal models.Tamibarotene is available as an oral tablet for the treatment of acute promyelocytic leukemia currently marketed in Japan. But when a high dose is administered to compensate for the insufficient lung distribution, toxic side effects are expected because of the extensive systemic exposure.The team, led by the University of Hong Kong (HKUMed), prepared the inhaled dry powder formulation of tamibarotene by spray freeze drying, a particle engineering technique that combines spray freezing and freeze drying to produce particles with excellent aerosol properties for inhalation.The researchers found that a dose of tamibarotene powder delivered by intratracheal administration significantly reduced virus titer and viral RNA load of SARS-CoV-2 in the hamsters' lungs, and the antiviral efficacy was comparable to intratracheally administered remdesivir.The broad-spectrum anti-coronavirus activity of inhaled tamibarotene powder was also demonstrated in MERS-CoV-infected mice model as pre-challenge prophylaxis.Moreover, remarkable anti-influenza activity of tamibarotene powder formulation was demonstrated by the improved survival rate of mice and alleviated disease severity when administered either intratracheally as prophylaxis or intranasally as treatment. The findings have been published online in Advanced Therapeutics."Currently, there is no inhaled powder formulation of antiviral available on the market for Covid-19 treatment. Tamibarotene dry powder with broad-spectrum antiviral activity presents a new strategy for Covid-19 management, especially as prophylaxis and treatment for outpatients when in-patient healthcare cannot be provided," said Jenny Lam, Associate Professor, Department of Pharmacology and Pharmacy, HKUMed."With the favourable safety profile of tamibarotene and based on the findings in the present study, clinical trials evaluating inhaled tamibarotene for its safety and as at-home treatment for Covid-19 could be considered," Lam said.Inhaled powder formulation of broad-spectrum antiviral drugs can be used on an outpatient basis due to the ease of (self-)administration as prevention and treatment for respiratory viral infections, the researchers said.Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

University Of Hong KongFOLLOW

University of hong kong, Latest News

Hong Kong, Dec 5 While more than 50 countries have stepped up border controls in the wake of ... ...

Scientists have warned that new travel restrictions are ineffective against the Omicron coronavirus strain and risk slowing down studies of the variant, according to a report by the journal Nature. ...

When it comes to obese patients it has been noticed that they have lower metabolism and endurance of skeletal muscle. A research team led by Dr Chi Bun Chan, Assistant Professor from School of Biological Sciences, Faculty of Science, the University o ...

The now-disbanded organiser of Hong Kong's Tiananmen Massacre vigil has been approached by the University of Hong Kong (HKU) to remove the Pillar of Shame, an artwork that pays tribute to victims of Beijing's 1989 crackdown from its campus, said a me ...

Hong Kong, Aug 17 The overall global death toll from suicide has risen by nearly 20,000 in the ... ...

Beijing, Aug 11 As the virus continues to mutate, new variants of Covid-19 will emerge so the world ... ...

Several students at the University of Hong Kong have been barred from entering the campus after they attended a student council meeting last month which passed a sympathy motion for a man who killed himself after stabbing a police officer. ...

Hong Kong, July 28 A team of researchers has developed an inhalable dry powder formulation of tamibarotene ... ...